Invention Grant
- Patent Title: Cytotoxic particles for targeting P2X7 receptor
-
Application No.: US16326882Application Date: 2017-08-18
-
Publication No.: US11260131B2Publication Date: 2022-03-01
- Inventor: Xiaojuan Gong , Minoo J Moghaddam , Julian Alexander Barden
- Applicant: BIOSCEPTRE (AUST) PTY LTD
- Applicant Address: AU North Ryde
- Assignee: BIOSCEPTRE (AUST) PTY LTD
- Current Assignee: BIOSCEPTRE (AUST) PTY LTD
- Current Assignee Address: AU North Ryde
- Agency: Bozicevic, Field & Francis LLP
- Agent James S. Keddie
- Priority: AU2016904292 20161021
- International Application: PCT/AU2017/050885 WO 20170818
- International Announcement: WO2018/071959 WO 20180426
- Main IPC: A61K47/69
- IPC: A61K47/69 ; A61K9/127 ; C07K16/28 ; A61K31/7068 ; A61P35/00 ; A61K47/54 ; C07K16/18 ; C07K16/30 ; A61K47/68 ; A61K9/16 ; A61K39/00
Abstract:
The invention relates to cytotoxic particles for cancer therapy including a core and a plurality of variable domains arranged on the core for binding to P2X7 preceptorson a cancer cell.
Public/Granted literature
- US20190201545A1 CYTOTOXIC PARTICLES Public/Granted day:2019-07-04
Information query
